Cornerstone Capital Management Holdings’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-7,054
| Closed | -$261K | – | 1276 |
|
|
2017
Q2 | $261K | Buy |
7,054
+375
| +6% | +$13.9K | ﹤0.01% | 1122 |
|
|
2017
Q1 | $361K | Buy |
+6,679
| New | +$361K | ﹤0.01% | 1099 |
|
|
2016
Q1 | – | Sell |
-441
| Closed | -$104K | – | 1500 |
|
|
2015
Q4 | $104K | Buy |
441
+114
| +35% | +$26.9K | ﹤0.01% | 1306 |
|
|
2015
Q3 | $52K | Sell |
327
-346
| -51% | -$55K | ﹤0.01% | 1399 |
|
|
2015
Q2 | $255K | Buy |
673
+6
| +0.9% | +$2.27K | ﹤0.01% | 1154 |
|
|
2015
Q1 | $279K | Buy |
667
+200
| +43% | +$83.7K | ﹤0.01% | 1121 |
|
|
2014
Q4 | $128K | Buy |
467
+154
| +49% | +$42.2K | ﹤0.01% | 1136 |
|
|
2014
Q3 | $61K | Sell |
313
-214
| -41% | -$41.7K | ﹤0.01% | 1206 |
|
|
2014
Q2 | $128K | Buy |
+527
| New | +$128K | ﹤0.01% | 1160 |
|